Biotech-oriented custom software development startup Lab7 Systems, Inc. of Austin has announced that the first beta release of its next-generation DNA sequencing (NGS) data workflow management software platform is now available as a free download for early-access users.
Described as a comprehensive sample-to-answer software environment, the Lab7 software is designed to streamline the process of managing and analyzing NGS data by integrating the current set of disparate tools. Lab7 says this initial customer testing is intended to introduce the novel software platform to NGS scientists, bioinformaticians, and core lab personnel, while the company gains useful insight into customer usage and workflows.
“We’re starting to lift the veil on our software by releasing Lab7 Public Beta to our core constituencies in the NGS space,” says Chris Mueller, Ph.D., Lab7 Systems’ President and CTO. “Through this release, we want to get valuable feedback that will help to shape our full-featured software, which is slated to launch in the fourth quarter of 2013. The NGS analysis pipeline engine and reporting tools we’re making available will be the first phase of a comprehensive workflow platform that will significantly change the way NGS data is processed.”
Lab7 Systems was created with a vision to reduce the level of hands-on data management by bioinformaticians, scientists, and IT teams who struggle with the massive amounts of next generation sequencing data being generated these days. With the huge reduction in cost of DNA sequencing, researchers are flocking to the technology, creating a massive big data problem. Simply managing sequencing data has cost the industry over $400 million in 2012 alone. The Lab7 team’s objective is to develop a tool that will integrate the disparate and often disjointed scientific software toolkit that is being used, thereby freeing up valuable human resources currently tasked with doing this. They are all scientists from the company’s core constituencies who have at one time or another faced these issues, and who’ve brought that experiential knowledge to the development process.
[adrotate banner=”9″]Lab7’s founder and visionary Christopher Mueller formerly led the RNA sequencing informatics group at Life Technologies, developing in-house sequencing analysis tools and advising senior management on sequencing informatics strategy. Dr. Mueller has worked in commercial and academic environments, developing software for scientific and Web apps and successfully launched proprietary and open source applications.
Lab7 Systems anticipates that it will reduce the burdened cost of DNA data handling over 80% by creating a solution that allows the management of data from sample submission all the way through meta-analyses. “In its full version, Lab7 will be a single-interface dashboard that will tie together all of the various tools we’ve been using in NGS,” says Dr. Mueller. “With all of the manual data shuffling and loose data provenance everyone is struggling through today, there are some very highly-skilled professionals who are spending inordinate amounts of time, and therefore their employers’ money, on tasks that can be automated. An integrated platform will allow users to get back to their primary goal – the advancement of science.”
“We founded Lab7 with the goal of becoming very involved with our users, and that’s why we’re so excited to get our software into users’ hands,” says Dr. Mueller. “With our strong focus on user experience, we firmly believe that we will deliver an easy-to-operate solution for our customer base, and we’re extremely anxious to start getting some great feedback from our early adopters.”The free release of the Lab7 pipeline management system is available on Lab7 Systems’ website (http://www.lab7.io) for academic and non-clinical use. Users of this version who wish to take advantage of the software’s support for compute clusters, parallel execution, access control lists and multiple users, are invited to contact Lab7 to receive early access to the full version of the software. Regular updates can be expected every four to six weeks.
For more information, visit: